Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
BioPharmaceutical

Aetna PBM Spin-Off Floated As Insurer Uncertainties Over Health Reform Grow

  • News

Executive Summary

News that Aetna is actively shopping around its internal pharmacy benefit management unit comes as insurers face growing uncertainty about how health care reform will impact their business

You may also be interested in...



Aetna Internal PBM No Longer In Play With CVS Caremark Contract

Aetna's new 12-year contract to merge some of its internal pharmacy benefit management operations with CVS Caremark appears to take Aetna's in-house PBM out of play as a potential acquisition target

Aetna Internal PBM No Longer In Play With CVS Caremark Contract

Aetna's new 12-year contract to merge some of its internal pharmacy benefit management operations with CVS Caremark appears to take Aetna's in-house PBM out of play as a potential acquisition target

Aetna Will Retain Formulary, Rebate Contracting Duties In CVS Caremark Contract

Aetna will retain responsibility for formulary contracting and drug rebate arrangements under its new 12-year pharmacy benefit management contract with CVS Caremark.

Table

View full table

Related Content

Pink Sheet
Pink Sheet

Topics

Tags:
BioPharmaceutical
Latest Headlines

Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa

Partisan Politics Returns To US FDA Congressional Oversight

GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows

Pink Sheet Podcast: Leqembi Spending, Woodcock’s Next Act, Pneumococcal Vaccine Development

See All
UsernamePublicRestriction

Register

PS051342

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By